When you're looking at a new investment for the first time, the best place to start is the company's last quarterly report. Take, for example, health-care stalwart and reliable dividend stock Johnson & Johnson (JNJ 0.29%). The company reported strong results and raised its guidance for the year; but what were the major growth drivers, and how does its valuation stack up against competitors like Abbott Labs (ABT 0.53%)? In the following video, a segment from The Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso examine the highs and lows of the company's second quarter.